Craft

Crescita Therapeutics

Stock Price

$0.6

2024-10-29

Market Capitalization

$11.6 M

2024-10-29

Revenue

$21.1 M

FY, 2025

Crescita Therapeutics Summary

Company Summary

Overview
Crescita is a commercial dermatology company with a portfolio of non-prescription skincare products and prescription drug products for the treatment and care of skin conditions and diseases and their symptoms. It owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active drugs into or through the skin.
Type
Public
Status
Active
Founded
2016
HQ
Laval, CA | view all locations
Website
http://www.crescitatherapeutics.com
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

LocationsView all

2 locations detected

  • Laval, QC HQ

    Canada

    2805 Place Louis-R.-Renaud

  • Mississauga, ON

    Canada

    610-6733 Mississauga Rd

Crescita Therapeutics Financials

Summary Financials

Revenue (Q1, 2026)
$C5.6M
Gross profit (Q1, 2026)
$C3.6M
Net income (Q1, 2026)
($C1.2M)
Cash (Q1, 2026)
$C8.7M
EBIT (Q1, 2026)
($C1.2M)

Footer menu